Youssef L. Bennani

The osmium-catalyzed asymmetric dihydroxylation: a new ligand class and a process improvement

K. Barry Sharpless, Willi M. Amberg, Youssef L. Bennani et al. · The Journal of Organic Chemistry · 1992 · 1.5K citations

Natural Sciences, Biochemistry, Chemistry +7

Pharmacological Properties of ABT-239 [4-(2-{2-[(2 R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological Characterization and Broad Preclinical Efficacy in Cognition and Schizophrenia of a Potent and Selective Histamine H3 Receptor Antagonist

Gerard B. Fox, Timothy A. Esbenshade, Jia Bao Pan et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 261 citations

Medicine, Neuroscience, Pharmacology +13

Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2

Michael P. Clark, Mark W. Ledeboer, Ioana Davies et al. · Journal of Medicinal Chemistry · 2014 · 211 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Rapamycin and Less Immunosuppressive Analogs Are Toxic to <i>Candida albicans</i> and <i>Cryptococcus neoformans</i> via FKBP12-Dependent Inhibition of TOR

Maria Cristina Cruz, Alan L. Goldstein, Jill R. Blankenship et al. · Antimicrobial Agents and Chemotherapy · 2001 · 162 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Syntheses and crystal structures of the cinchona alkaloid derivatives used as ligands in the osmium-catalyzed asymmetric dihydroxylation of olefins

Willi M. Amberg, Youssef L. Bennani, Raj K. Chadha et al. · The Journal of Organic Chemistry · 1993 · 126 citations

Natural Sciences, Chemistry, Medicinal Chemistry +7